FDA recall D-326-2014

Novartis Pharmaceuticals Corp. · Class II · drug

Product

Diovan (valsartan) 160 mg per tablet, 7 Tablets per bottle, Rx only Physician Sample Not For Sale, Manufactured by: Novartis Pharmaceuticals Corporation Suffern, NY 10901 for Novartis Pharmaceuticals Corporation East Hanover, NJ 07936, NDC # 0078-9359-07

Reason for recall

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Distribution

Nationwide and Puerto Rico

Key facts

Status
Terminated
Initiation date
2013-08-08
Report date
2013-12-18
Termination date
2015-12-21
Voluntary/Mandated
Voluntary: Firm initiated
Location
Suffern, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-326-2014